Abstract
This study investigates the advantages of implementing Oncofix’s questionnaire-based artificial intelligence (AI) tool for cancer screening. The study comprises a risk stratification analysis involving 9,000 participants, followed by subsequent screening for various cancers. The outcomes demonstrate the tool’s effectiveness in identifying individuals at high risk, leading to the early detection of prostate, colon, lung, and breast cancers. This research highlights the potential of AI-based screening tools in improving early detection rates, optimising resource allocation, and enhancing patient outcomes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
